ValiRx Plc Announces Board Chairman Resignation
Company Announcements

ValiRx Plc Announces Board Chairman Resignation

ValiRx plc (GB:VAL) has released an update.

ValiRx Plc, a life science company dedicated to developing early-stage cancer therapeutics and women’s health solutions, has announced the immediate resignation of Kevin Cox as Chairman and Director. The company, which has been listed on the AIM Market of the London Stock Exchange since October 2006, is known for its innovative approach to streamlining drug development processes and bringing novel drug candidates to clinical development and commercialization.

For further insights into GB:VAL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskValiRx Extends Exclusivity Agreement with TheoremRx
TipRanks UK Auto-Generated NewsdeskValiRx plc Announces Board Changes Amid Strategic Focus
TipRanks UK Auto-Generated NewsdeskValiRx plc to Reveal Future Strategies in CEO Webinar
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App